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Summary
Red wine is the main source of resveratrol. It oc-
curs in both, isomeric (trans- and cis-) and in its gluco-
sides forms. The grapevine variety, climate, conditions 
and duration of wine storage, and phytosanitary condi-
tions of grape are some of the factors  that influence 
content of resveratrol. This study analyzed trans- and 
cis-resveratrol isomers concentrations and trans-res-
veratrol-3-O-glucoside and cis-resveratrol-3-O-gluco-
side concentrations among three clone candidates and 
population of autochthonous Montenegrin grapevine 
variety ‘Vranac’. Data from period of three years were 
collected and analyzed with UPLC-MS/MS. Results 
showed no statistically significant difference (p = 0.169) 
in concentration of resveratrol among three clone can-
didates and population of grapevine variety ‘Vranac’.
K e y  w o r d s :  clones; UPLC-MS/MS; stilbenes; grape-
vine populations.
Introduction
‘Vranac’ is an autochthonous grapevine variety of 
Montenegro, with a significant importance for the viticul-
ture and winemaking industries, and for the Montenegrin 
economy in general. ‘Vranac’ grapes have been used for 
the production of premium quality red wines. However, 
since 2004, researchers worked on developing clones 
with improved agro-biological, economical and techno-
logical characteristics. As part of this project three year 
(2010-2012) research was conducted in order to determine 
the concentration of resveratrol in wine of three putative 
‘Vranac’ clones.
Resveratrol is a member of the stilbene family and it 
can exist in cis- or trans- configurations (trans-3, 5, 4’-
trihydroxystilbene), or as glucosylated forms called piceid 
(resveratrol-3-O-beta-mono-D-glucoside) (Figure). Both 
trans- and cis-resveratrol are known as phenolic bioactive 
wine constituents. Phenolic compounds are an important 
group of substances in wine that contribute to several sen-
sory characteristics, such as color, flavor and astringency 
(FRÉMONT 2000). Furthermore, it has been reported that 
phenols have multiple biological effects, such as antioxi-
dant activity, anti-inflammatory action, inhibition of plate-
let aggregation and antimicrobial activity (ĐEKIĆ et al. 
2008).
Concentration of resveratrol in wine depends on mul-
tiple factors. It is known that resveratrol is synthesized in 
the plant in response to infection caused by fungal diseases 
such as Botrytis cinerea or due to abiotic stress such as 
UV radiation excess. It is assumed that the UV-B radiation 
stimulates the production of enzymes responsible for the 
synthesis of stilbene, in order to protect berry cells from 
UV-induced damages (LANGCAKE et al. 1976). Red wines 
and grapes present higher levels of resveratrol than white 
grape products (MORENO et al. 2008). Cis-isomer is pro-
duced by UV irradiation of the trans-isomer (MORENO et 
al. 2008). It is generally absent or only slightly detectable 
in grapes, but both isomers are present in variable amounts 
in commercial wines (CVEJIĆ at al. 2010).
Cis-resveratrol was not reported at first as a natural 
constituent of grape berries (JEANDET et al. 1991, JEANDET 
et al. 1995). However, later, MORENO et al. 2008, detected 
cis-isomer in red grape skins. Moreover, cis-resveratrol 
and its glucoside have been detected in wines. More like-
ly, cis-resveratrol is derived from its trans-isomer during 
vinification (CVEJIĆ et al. 2010) even if the mechanisms of 
its formation during winemaking are still unclear (DOUR-
TOGLOU et al. 1999).
Piceid is a derivative of resveratrol. The average con-
tent of piceid was found ten times higher than that of res-
veratrol in the root of Polygonum cuspidatum and in red 
wine (DAN et al. 2013). Additionally, piceid was the most 
abundant form of resveratrol in nature (REGEV-SHOSHA-
NI et al. 2003). A number of studies have suggested that 
piceid may also have anti-carcinogenic effects (SOLEAS 
et al. 2001), inhibition of platelet aggregation (CHUNG 
Correspondence to: Dr. B. RADOVIC, Jelene Balšić 18, 81000 Podgorica, Montenegro. E-mail: radovicbojan081@gmail.com
Figure: Structures of free and glycosylated trans- and cis- resveratrol forms.
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et al. 1992, ORSINI et al. 1997), and anti-oxidation activity 
(BROHAN et al. 2011). This work aimed at developing new 
‘Vranac’ clones with high concentrations in resveratrol and 
its glucoside. The goal of the study was to determine con-
centrations of stilbenes (trans- and cis-resveratrol and its 
piceid) in three developed clones and to statistically test 
the difference in resveratrol concentrations between clones 
and population of ‘Vranac’ variety. 
Material and Methods
Wines from the ‘Vranac’ population and its three pu-
tative clones were produced in the experimental winery 
of Plantaze Co. Standard vinifications were performed in 
Ganimede® tanks. Potassium meta-bisulfite (Agroterm 
KFT, Hungary) was added (8 g∙100 kg-1 of grapes). All en-
zymes, wine yeast, lactic acid bacteria and yeast nutrients 
were purchased from Lallemand, Australia. In more details, 
Enoferm BDX (30 g∙hL-1) ; Go-ferm protect (30 g∙hL-1); 
Lalvin EX-V (2 g∙100 kg-1); Fermaid E (25 g∙hL-1) were 
added during fermentation. For malolactic fermentation 
commercial lactic acid bacteria Lalvin VP41 was used for 
inoculation.
The analyses were performed on four wine samples 
produced in three years (2010, 2011, 2012).Trans-resvera-
trol standard was purchased from Sigma Chemical Co. (St.
Louis, MO). Cis-resveratrol is not commercially available 
and was therefore obtained through UV-photoisomeriza-
tion (280-310 nm, for 10 h) of a standard solution (100 
mg∙L-1) of trans-resveratrol. Under these conditions, 80 % 
of the trans-resveratrol was converted into the cis-isomer.
U P L C  M S / M S  a n a l y s e s :  Analyses of res-
veratrol was carried out on Waters Acquity UPLC H-Class 
(WAT-176015007) equipped with a quaternary pump 
Waters Quaternary Solvent Menager; an injector Waters 
Sample Menager-FTN (Flow Through Needle); a column 
compartment with a ZORBAX Eclipse XDB C18 column 
(150 × 4,6 mm; 5 µm); a Photodiode Arraydetector Wa-
ters 2998 PDA and a mass detector Waters TQ (Tandem 
Quadrupole, WAT-176001263). For data acquisition and 
processing, the software MassLynx® V4.1 was used.
The mobile phase consists of 0.2 % fumaric acid in 
H
2
O (A) and acetonitrile (B). The chromatographic separa-
tion was performed using a six stage linear gradient: from 
5 % to 16  % of B in 20 min, from 16 to 40 % of B in 8 min, 
from 40 % to 70 % of B in 4 min, from 70 to 100 % of B 
in 4 min, and at 100 % of B during 9 min, and back to 5 % 
of B in 9 min, with a total flow rate of 0.7 mL∙min-1. The 
total gradient time was 55 min. The separation temperature 
was set up at 25 °C. UV-visible spectra were recorded in 
the wavelength range from 190 nm to 600 nm. Injection 
volume was 10 µL. MS Scan standard resveratrol was re-
corded in ESI- and ESI+ mode. The transition m/z 229→
107 was monitored in ESI+ MRM mode (Multiple Reaction 
Monitoring Mode) under the following conditions: capil-
lary voltage at 3.5 kV, the cone voltage 34 V, collision ener-
gy of 24 eV, the source temperature of 150 °C, desolvation 
temperature of 450 °C, flow of desolvation gas 800 L∙h-1. 
The samples were analyzed without prior preparation: they 
were only filtered through a filter Econofilter 25/0.45 µm.
Calibration graphs were obtained by plotting the peak 
area against the concentration. Five standards of trans- and 
cis-resveratrol were used covering the range 0.05-5 mg∙L-1. 
Concentration for trans- and cis-piceid were obtained from 
calibration graphs for trans- and cis-resveratrol respective-
ly. The resveratrol concentration among the 4 ‘Vranac’-
types (Clone 1, Clone 2, Clone 3 and Population) over 
three years were compared and statistically tested using re-
peated measures ANOVA (p = 0.05). SPSS® 15.0 software 
was used for statistical analysis.
Results and Discussion
The results of resveratrol concentration variabil-
ity among the 4 ‚Vranac’-types, obtained from the wine 
analysis, are summarized in the Table. Results showed that 
the highest average concentration of trans-piceid (1.123 
mg∙L-1) was found in C lone III, while the highest aver-
age concentration of cis-piceid (1.193 mg∙L-1) was found in 
the Population sample. The highest average concentration 
of trans-resveratrol (0.600 mg∙L-1) among all the samples 
was found in the Population sample. The highest average 
concentration of total resveratrol (3.119 mg∙L-1) was found 
in Clone I.
Resveratrol concentrations among the 4 ‘Vranac’-types 
were statistically tested using repeated measure analysis 
of variance (rANOVA) at p = 0.05. Results showed that 
there was no statistically significant difference in total con-
centration of resveratrol among the tested ‘Vranac’-types 
(F(3,6) = 2.373, p < 0.169). Similarly, results showed that 
T a b l e
Concentrations (mean and st. dev.) of trans-resveratrol (mg∙L-1), cis-resveratrol (mg∙L-1), c-resveratrol-3-O-glucoside 
(mg∙L-1) and cis-resveratrol-3-O-glucoside (mg∙L-1) in wine of population of 'Vranac' variety and its putative clones in 
period 2010- 12 in Plantaze A.D. winery, Podgorica, Montenegro
Resveratrol (mg∙L-1) Population putative Clone I putative Clone II putative Clone III
trans-resveratrol 0.600 (0.129) 0.485 (0.084) 0.414 (0.062) 0.457 (0.107)
cis-resveratrol 0.380 (0.058)a 0.318 (0.049) 0.295 (0.084) 0.190 (0.174)
trans-resveratrol-3-O-glucoside 0.834 (0.344) 1.123(0.196) 0.837 (0.237) 1.179 (0.067)
cis-resveratrol-3-O-glucoside 0.506 (0.162)a 1.193 (0.323)b 0.870 (0.090)ab 0.988 (0.030)b
Total 2.320 (0.317) 3.119 (0.596) 2.416 (0.180) 2.914 (0.317)
In the same line, when reported, means followed by the same letter are not statistically different.
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there was no statistically significant difference in concen-
tration of trans-resveratrol among the tested ‘Vranac’-types 
(F(3,6) = 2.730, p < 0.169) either. 
The only statistically significant difference found 
concerned in the variability in cis-resveratrol concentra-
tion among the tested ‘Vranac’-types (F(3,6) = 29.876, 
p < 0.032). However, Tuckey post-hoc tests (with Bonfer-
roni adjustment for multiple comparisons) showed that 
neither cis-resveratrol concentration among ‘Vranac’-types 
was statistically significant at p = 0.05. Finally, results 
showed that there was a statistically significant difference 
in concentration of cis-resveratrol-3-O-glucoside among 
the tested ‘Vranac’-types (F (3,6) = 70.087, p < 0.033). 
Tuckey post-hoc tests (with Bonferroni adjustment for 
multiple comparisons) showed that a statistically signifi-
cant difference in cis-resveratrol-3-O-glucoside concentra-
tion among the tested ‘Vranac’-types was found between 
the Population wines and Clone III pair (at p = 0.024), 
and between Clone II and Clone III pair (at p = 0.039). 
Similarly, the results showed that there was a statistically 
significant effect of concentration of cis-resveratrol among 
the tested ‘Vranac’-types (F(3,6) = 29.876, p < 0.032). 
However, Tuckey post-hoc tests (with Bonferroni adjust-
ment for multiple comparisons) showed that cis-resveratrol 
concentration among groups was not statistically signifi-
cant at p = 0.05.
The study was conducted with the primary focus being 
directed on the determination of trans-resveratrol and cis-
resveratrol levels and their piceid in ‘Vranac’ wines. While 
there are numerous factors that could have impacted the 
total content of resveratrol (such as environmental and cli-
mate conditions), results indicate that ‘Vranac’ clones have 
the same capacity to produce resveratrol concentrations in 
wine as the ‘Vranac’ population.
References
BROHAN, M.; JERKOVIC, V.; COLLIN, S.; 2011: Potentiality of red sorghum 
for producing stilbenoid-enriched beers with high antioxidant activ-
ity. J. Agric. Food Chem. 59, 4088-4094. 
CHUNG, M. I.; TENG, C. M.; CHENG, K. L.; KO, F. N.; LIN, C. N.; 1992: 
An antiplatelet principle of Veratrum formosanum. Planta Med. 58, 
274-276.
CVEJIĆ, J.; ĐEKIĆ, S.; PETROVIĆ, A.; ATANACKOVIC, A.; JOVIĆ, S.; BRCESKI, 
I.; GOJKOVIĆ-BUKARICA, L.; 2010: Determination of trans- and cis-
Resveratrol in Serbian commercial wines. J. Chromatogr. Sci. Vol. 
48, 229-234.
DAN, S.; YING, C.; MIAO, L.; DAOZHOU, L.; HAN, C.; BANGLE, Z.; SIYUAN, 
Z.; TIEHONG, Y.; QIBING, M.; 2013: Comparision of piceid and resver-
atrol in antioxidation and antiproliferation activities in vitro. PLoS 
ONE 8, e54505.
ĐEKIĆ, S.; MILOSAVLJEVIĆ, S.; VAJS, V.; JOVIĆ, S., PETROVIĆ, A.; NIKIĆEVIĆ, 
N.; MANOJLOVIĆ, V.; NEDOVIĆ, V.; TEŠEVIĆ, V.; 2008: Trans- and 
cis-resveratrol concentration in wines produced in Serbia, J. Serb. 
Chem. Soc. 73, 1027-1037.
DOURTOGLOU, V. G.; MAKRIS, D. P.; BOIS-DOUNAS, D.; ZONAS C.; 1999: 
Trans-resveratrol concentration in wines produced in Greece. J. 
Food Comp. Anal. 12, 227-233.
FREMONT, L.; 2000: Biological effects of resveratrol. Life Sci. 66, 
663-673.
JEANDET, P.; BESSIS R.; GAUTHERON, B.; 1991: The production of resvera-
trol (3.5.4’-trihydroxystilbene) by grape berries in different develop-
mental stages. Am. J. Enol. Vitic. 42,41-46.
JEANDET, P.; BESSIS, R.; MAUME, B. F.; MEUNIER, P.; PEYRON, D.; TROLLAT, 
P.; 1995: Effect of enological practices on the resveratrol isomer 
content of wine. J. Agric.Food Chem. 43, 316-319.
JEANDET, P.; BESSIS, R.; SBAGHI, M.; MEUNIER, P.; TROLLAT, P.; 1995: Res-
veratrol content of wines of different ages: Relationship with fungal 
disease pressure in the vineyard. Am. J. Enol. Vitic. 46, 1-4.
LANGCAKE, P.; PRYCE, R. J; 1976: The production of resveratrol by Vitis-
vinifera and other members of the Vitacee as a response to infection 
or injury. Phys. Plant Pathol. 9,77-86.
MORENO, M.; CASTRO, E.; FALQUÉ, E.; 2008: Evolution of trans- and 
cis- resveratrol content in red grapes (Vitis vinifera L. cv Menciá, 
Albarello and Merenzao) during ripening. Eur. food Res. Technol. 
227,667-674.
ORSINI, F.; PELIZZONI, F.; VEROTTA, L.; ABURJAI, T.; ROGERS C.B.; 1997: Iso-
lation, synthesis, and antiplatelet aggregation activity of resveratrol 
3-O-beta-Dglucopyranoside and related compounds. J. Nat. Prod. 
60, 1082-1087.
REGEV-SHOSHANI, G.; SHOSEYOV, O.; BILKIS, I.; KEREM, Z.; 2003: Glyco-
sylation of resveratrol protects it from enzymic oxidation. Biochem. 
J. 374, 157-163.
SOLEAS, G. J.; GOLDBERG, D. M.; GRASS, L.; LEVESQUE, M.; DIAMANDIS, E. 
P.; 2001: Do wine polyphenols modulate p53 gene expression in hu-
man cancer cell lines? ClinBiochem 34, 415-42.
 Resveratrol concentration in ‘Vranac‘ wines 171

